Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06007482
What this trial is testing

ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
Elpiscience Biopharma Australia Pty. Ltd. 12
Early research (Phase 1)Study completedNCT00569036
What this trial is testing

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

Who this might be right for
NeoplasmsSolid TumorsMetastases
Bristol-Myers Squibb 63
Early research (Phase 1)Ended earlyNCT06535009
What this trial is testing

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Ono Pharmaceutical Co., Ltd. 25
Early research (Phase 1)Active Not RecruitingNCT05385692
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Digestive Tract TumorsSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 22
Testing effectiveness (Phase 2)Study completedNCT01379534
What this trial is testing

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Who this might be right for
Solid Tumors and Advanced Endometrial CancerEndometrial CancerSecond-line Treatment+1 more
Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)Looking for participantsNCT07262619
What this trial is testing

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Who this might be right for
Advanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more
Eikon Therapeutics 160
Not applicableNot Yet RecruitingNCT07599007
What this trial is testing

Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 10
Early research (Phase 1)Study completedNCT00119236
What this trial is testing

17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)UnknownNCT05145907
What this trial is testing

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

Who this might be right for
Triple-negative Breast CancerHead and Neck Squamous Cell Carcinoma
TJ Biopharma Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Study completedNCT05830539
What this trial is testing

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
InxMed (Shanghai) Co., Ltd. 68
Early research (Phase 1)Looking for participantsNCT07606612
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)WithdrawnNCT07511972
What this trial is testing

Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
CRC
NGM Biopharmaceuticals, Inc
Early research (Phase 1)Looking for participantsNCT04093466
What this trial is testing

CX1003 (Kanitinib) in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Beijing Konruns Pharmaceutical Co., Ltd. 126
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282873
What this trial is testing

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor MalignanciesMalignant Mesothelioma (MM)
TYK Medicines, Inc 219
Early research (Phase 1)Ended earlyNCT01642342
What this trial is testing

Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Southern California 102
Large-scale testing (Phase 3)Study completedNCT04887870
What this trial is testing

Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study

Who this might be right for
Advanced or Metastatic Solid Malignancies
Mirati Therapeutics Inc. 49
Early research (Phase 1)Study completedNCT02018874
What this trial is testing

A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine

Who this might be right for
Solid Tumors and Non-Hodgkin's Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 52
Early research (Phase 1)Study completedNCT00126620
What this trial is testing

Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University Health Network, Toronto 17
Early research (Phase 1)Ended earlyNCT00363610
What this trial is testing

A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma

Who this might be right for
TumorsLymphoma
Enzon Pharmaceuticals, Inc. 19
Next Page